Mark T Iwicki - Net Worth and Insider Trading

Mark T Iwicki Net Worth

The estimated net worth of Mark T Iwicki is at least $3 Million dollars as of 2024-04-28. Mark T Iwicki is the CHIEF EXECUTIVE OFFICER of Kala Bio Inc and owns about 286,315 shares of Kala Bio Inc (KALA) stock worth over $2 Million. Mark T Iwicki is also the Director of Aimmune Therapeutics Inc and owns about 29,375 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $1 Million. Details can be seen in Mark T Iwicki's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark T Iwicki has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).

Transaction Summary of Mark T Iwicki

To

Mark T Iwicki Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark T Iwicki owns 7 companies in total, including Aimmune Therapeutics Inc (AIMT) , Merus NV (MRUS) , and Kala Bio Inc (KALA) among others .

Click here to see the complete history of Mark T Iwicki’s form 4 insider trades.

Insider Ownership Summary of Mark T Iwicki

Ticker Comapny Transaction Date Type of Owner
AIMT Aimmune Therapeutics Inc 2020-10-10 director
MRUS Merus NV 2021-05-28 director
KALA Kala Bio Inc 2024-01-04 director & Chief Executive Officer
AKRO Akero Therapeutics Inc 2022-06-02 director
PULM Pulmatrix Inc 2015-12-08 director
AVTE Aerovate Therapeutics Inc 2021-06-29 director
THRD Third Harmonic Bio Inc 2022-09-14 director

Mark T Iwicki Latest Holdings Summary

Mark T Iwicki currently owns a total of 2 stocks. Among these stocks, Mark T Iwicki owns 286,315 shares of Kala Bio Inc (KALA) as of January 4, 2024, with a value of $2 Million and a weighting of 64.03%. Mark T Iwicki also owns 29,375 shares of Aimmune Therapeutics Inc (AIMT) as of February 26, 2018, with a value of $1 Million and a weighting of 35.97%.

Latest Holdings of Mark T Iwicki

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KALA Kala Bio Inc 2024-01-04 286,315 6.30 1,803,785
AIMT Aimmune Therapeutics Inc 2018-02-26 29,375 34.49 1,013,144

Holding Weightings of Mark T Iwicki


Mark T Iwicki Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark T Iwicki has made a total of 7 transactions in Kala Bio Inc (KALA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Kala Bio Inc is the sale of 4,539 shares on January 4, 2024, which brought Mark T Iwicki around $30,548.

According to the SEC Form 4 filings, Mark T Iwicki has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 9,375 shares on February 26, 2018, which cost Mark T Iwicki around $300,000.

Insider Trading History of Mark T Iwicki

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark T Iwicki Trading Performance

GuruFocus tracks the stock performance after each of Mark T Iwicki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark T Iwicki is -7.63%. GuruFocus also compares Mark T Iwicki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark T Iwicki within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark T Iwicki's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark T Iwicki

Average Return

-31.43%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.26 -7.63 -19.26 -31.43 -7.58 7.25
Relative Return to S&P 500(%) 11.38 -6.36 -14.85 -34.12 -14.64 -3.53

Mark T Iwicki Ownership Network

Ownership Network List of Mark T Iwicki

No Data

Ownership Network Relation of Mark T Iwicki


Mark T Iwicki Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Mark T Iwicki is the director of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aimmune Therapeutics Inc Insider Transactions

No Available Data

Mark T Iwicki Mailing Address

Above is the net worth, insider trading, and ownership report for Mark T Iwicki. You might contact Mark T Iwicki via mailing address: 84 Waterford Drive, Marlborough Ma 01752.

Discussions on Mark T Iwicki

No discussions yet.